Calcifediol Anhydrous

Calcifediol Anhydrous

SCHEMBL263480

C=C1CC[C@H](O)C/C1=C/C=C1CCC[C@@]2(C)C1CC[C@@H]2[C@H](C)CCCC(C)(C)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

VDR

The experimentally established mechanism targets of Calcifediol Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VDR known ✓ P11473 8/20 0.82
MAPT P10636 5/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
SREBF1 P36956 1/20 1.00
MEN1 O00255 3/20 0.82
KMT2A Q03164 3/20 0.82
ALDH1A1 P00352 2/20 0.82
CYP3A4 P08684 2/20 0.82
ALOX15 P16050 2/20 0.82
PGR P06401 2/20 0.82
ADORA3 P0DMS8 2/20 0.82
TDP1 Q9NUW8 1/20 0.82
CDC25A P30304 1/20 0.82
HSPD1 P10809 1/20 0.82
HPGD P15428 1/20 0.82
TBXA2R P21731 1/20 0.82
PTGS1 P23219 1/20 0.82
GLRA1 P23415 1/20 0.82
DRD3 P35462 1/20 0.82
HSPE1 P61604 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Calcifediol Anhydrous SCHEMBL10018928 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1
Calcifediol Anhydrous SCHEMBL13301741 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1
Calcifediol Anhydrous SCHEMBL9933434 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1
Calcifediol Anhydrous SCHEMBL3296 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1
Calcifediol Anhydrous SCHEMBL24102681 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1
Calcifediol Anhydrous SCHEMBL5614025 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1
Calcifediol Anhydrous SCHEMBL24051907 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1
Calcifediol Anhydrous SCHEMBL14112503 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1
Calcifediol Anhydrous SCHEMBL24571935 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1
Calcifediol Anhydrous SCHEMBL22403256 1.00 MAPT (1.00) MAPTSMN1; SMN2SREBF1VDRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6008 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104734-A1 INJECTABLE COMPOSITION OF 25-HYDROXY-VITAMIN D3 DSM IP ASSETS B.V. (NL) 2026-05-21 WO claimed
US-20260140108-A1 EXTRACTION ROD AND PREPARATION METHOD THEREOF, AND METHOD FOR DETECTING 25-HYDROXYVITAMIN D INNOVATION CENTER OF YANGTZE RIVER DELTA ZJU (CN) 2026-05-21 US claimed
US-12630852-B2 Modified sterol acyltransferases DSM IP ASSETS B.V. (NL) 2026-05-19 US claimed
US-12622879-B2 Transdermal delivery formulation TRS II, LLC (US) 2026-05-12 US claimed
US-12607640-B2 Mass spectrometry of steroidal compounds in multiplex samples QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) 2026-04-21 US claimed
US-12596126-B2 Methods for the prediction, prognosis, and/or diagnosis of an inflammatory response associated with schizophrenia Meier, Ute-Christiane (DE) 2026-04-07 US claimed
EP-3808750-B1 TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND TOKUYAMA CORP (JP) 2026-04-01 EP claimed
EP-4711765-A2 MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEX SAMPLES Quest Diagnostics Investments Incorporated (US) 2026-03-18 EP claimed
US-12576102-B2 Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability SOCIETE DES PRODUITS NESTLE S.A. (CH) 2026-03-17 US claimed
EP-4707402-A1 BIOELECTROCHEMICAL HYDROXYLATION OF SUBSTRATES USING FUNCTIONAL WATER-DEPENDENT ALKYL-HYDROXYLASE HYBRID ELECTRODES AND RESPECTIVE BIOFILM HYBRID ELECTRODES Albert-Ludwigs-Universität Freiburg Körperschaft des öffentlichen Rechts (DE) 2026-03-11 EP claimed
WO-1984004527-A1 PROCESS FOR THE PREPARATION OF 1alpha,25-DIHYDROXYLATED VITAMIN D2 AND RELATED COMPOUNDS WISCONSIN ALUMNI RES FOUND (US) 1984-11-22 WO claimed
US-4481356-A MEDICAL DIAGNOSIS THE UPJOHN COMPANY (US) 1984-11-06 US claimed
EP-0077353-A1 1-HYDROXYLATION PROCESS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1983-04-27 EP claimed
WO-1982004051-A1 MIXTURE OF HYDROXYLATED VITAMIN D DERIVATIVES SUITABLE FOR PREVENTING PARTURIENT PARESIS IN DAIRY CATTLE WISCONSIN ALUMNI RES FOUND (US) 1982-11-25 WO claimed
WO-1982003864-A1 1-HYDROXYLATION PROCESS WISCONSIN ALUMNI RES FOUND (US) 1982-11-11 WO claimed
US-4330537-A PHOSPHONATE COMPOUNDS AND VITAMIN D DERIVATIVES USEFUL AGAINST OSTEOPORSIS THE PROCTER & GAMBLE COMPANY (US) 1982-05-18 US claimed
WO-1982000465-A1 PROCESS FOR PREPARING VITAMIN D-LACTONES WISCONSIN ALUMNI RES FOUND (US) 1982-02-18 WO claimed
US-4310522-A THICKENED EGG SHELLS COMPRISING CALCIUM SOURCE AND A HYDROXY CHOLECALCIFEROL THE UPJOHN COMPANY (US) 1982-01-12 US claimed
US-4230700-A ADMINISTERING AN ORGANIC MONO- OR DIPHOSPHONATE AND A VITAMIN-D-LIKE ANTIRACHITIC COMPOUND THE PROCTER & GAMBLE COMPANY (US) 1980-10-28 US claimed
US-4004003-A PROPHYLAXIS, GLUCOCORTICOIDS THE UPJOHN COMPANY (US) 1977-01-18 US claimed